ELEDON PHARMACEUTICALS INC (ELDN) Stock Income Statement
NASDAQ:ELDN - Nasdaq - US28617K1016 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 70.58M | 43.00M | 39.78M | 36.87M | 16.19M | |||
| Research and Development | 51.96M | 30.31M | 27.08M | 23.74M | 6.13M | |||
| Selling, General, and Administrative Expenses | 18.61M | 12.69M | 12.70M | 13.13M | 10.05M | |||
| Operating Income | -70.58M | -43.00M | -39.78M | -36.87M | -16.19M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Other Income/Expense | 34.82M | -73.54M | 460.00K | 10.00K | -4.75M | |||
| Non Recurring Items | N/A | 0.00 | -48.65M | 0.00 | -2.28M | |||
| Income Before Taxes | -35.75M | -116.54M | -87.97M | -36.86M | -23.22M | |||
| Income Tax | 431.00K | 0.00 | 0.00 | -2.35M | -400.00K | |||
| Net Income | -36.18M | -116.54M | -87.97M | -34.51M | -22.81M | |||
| EBITDA | N/A | N/A | N/A | N/A | -16.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.75 | -4.73 | -6.16 | -2.33 | -15.72 | |||
| Non GAAP EPS | -1.05 | -1.79 | -2.76 | -2.32 | -13.21 | |||
| Statistics | ||||||||
All data in USD